What are the opening hours?

Monday 10:30am - 6pm Tuesday 10:30am - 6pm Wednesday 10:30am - 6pm Thursday 10:30am - 6pm Friday 10:30am - 6pm Saturday 10:30am - 6pm

Fuda Cancer Hospital - India

Home
India
Mumbai
Fuda Cancer Hospital - India

Fuda Cancer Hospital is famous for advance robotics & minimally invasive treatments. Cancer treatment varies from patient to patient.

It is located in Guangzhou (China) & have a consulting clinic and information centre in Mumbai (India). Fuda is committed to providing cancer patients around the world with the best medical care. Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life. Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family. To date, patients from over 110 countries were treated in Fuda and 50% of them are from South-East Asia, the Middle East, Oceania, Europe and North America. The number of patients treated in Fuda with Minimally Invasive treatments outnumbers any other hospital in the world. Fuda has received various awards in China and abroad for outstanding achievements in treating cancers and has been highly praised by patients worldwide.

07/11/2025

[Minimally invasive treatment] [Melanoma – Cryoablation]

Melanoma with Multiple Metastases: Hydro-Isolation Makes Cryoablation Safer

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

31/10/2025

[Minimally invasive treatment] [Pancreatic Cancer – NanoKnife]

NanoKnife Precisely Ablates the “No-Go Zone” of Pancreatic Cancer Surgery

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

25/10/2025

[Minimally invasive treatment] [HongKong – Pancreatic Cancer – NanoKnife]

NanoKnife for Pancreatic Cancer with Liver Metastases

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in

21/10/2025

[Minimally invasive treatment] [China – Lung nodules – Cryoablation]

Intraoperative biopsy confirms lung cancer: elderly patient opts for cryoablation

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

10/10/2025

[Patient’s Stories] [China – Lung Cancer – Cryoablation]

Trusted by an Athlete with Late-stage Lung Cancer

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

30/09/2025

[Patient’s Story] [Hong Kong – Nasopharyngeal Carcinoma – Interventional Therapy]

Hong Kong Patient with Nasopharyngeal Carcinoma Rewrites His Fate at Fuda Cancer Hospital !

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +86 15920523797
🌟 WhatsApp: +86 15920523797
🌍 Website: https://en.fudahospital.com/

16/09/2025

[Patient’s Story] [Kazakhstan – Breast Cancer – Interventional Therapy]

Breast Cancer Misdiagnosed as Mastitis !
A Kazakh Mother Fightfor Survival

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in

09/09/2025

[Patient’s Story] [Kazakhstan – Olfactory Neuroblastoma – Intra-Arterial Chemotherapy]

Kazakh Madam Defeats Rare Nasal Cancer at Fuda Cancer Hospital

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +86 15920523797
🌟 WhatsApp: +86 15920523797
🌍 Website: https://fudahospital.in/

08/09/2025

Testicular cancer
Testicular cancer primarily affects young and middle-aged men and is one of the most treatable cancers when diagnosed early. However, if left undiagnosed or untreated, it may lead to infertility, hormonal imbalances, and metastasis to organs such as the lungs, brain, and abdomen. The psychological and emotional impacts—especially in younger men—are also significant. Raising awareness through education, self-examination practices, and regular checkups is key to early detection and prevention of complications.

Tap: https://fudahospital.in/testicular-cancer/

.in .com

04/09/2025

[Patient’s Story] [Kazakhstan – Breast Cancer – Interventional Therapy]

Breast Cancer Misdiagnosed as Mastitis! A Kazakh Mother Fight for Survival

The discomfort in her chest was overshadowed by the joy of becoming a new mother and the liveliness of her child. Aigerim (pseudonym) silently endured the mild pain without much concern. It wasn’t until the moment she was diagnosed with cancer that she truly realized the seriousness of her condition…
“Mastitis” That Never Healed—Eventually Diagnosed as Breast Cancer!
Aigerim, a 35-year-old from Kazakhstan, was diagnosed with HER2-positive breast cancer at the end of October 2024. The cancer did not arrive without warning.
Years earlier, during a routine check-up, a small lump was found in her left breast. Local doctors told her it was likely a cyst caused by residual milk after childbirth, and that the lump would naturally disappear once her hormone levels stabilized. At the time, she had already stopped breastfeeding for a year. Trusting the doctors, she didn’t pursue further tests.
During her second pregnancy in 2024, as she approached delivery, the lump gradually grew, and her skin became red, swollen, and warm. Believing it to be mastitis caused by blocked milk ducts, she paid little attention. But after her baby was born, the lump did not disappear—it grew to 10 cm in size and was accompanied by fever. Local doctors still diagnosed it as chronic mastitis and prescribed only anti-inflammatory drugs and antibiotics.
“Fortunately, some other doctors suspected my case and advised me to undergo a mammogram,” she recalled. Ultimately, imaging and biopsy confirmed the diagnosis: Breast cancer, HER2 (+++), Grade 3 (G3) - High grade

Obvious atypia, grows fast, prone to metastasis
△ Breast cancer grading indicates tumor malignancy, expressed as G1, G2, or G3 in pathology reports.

Chemotherapy-Induced Liver Damage? A Mother’s Courage to Seek a Way Out
Aigerim received one cycle of intravenous chemotherapy locally, but the severe side effects deterred her from continuing. “After chemotherapy, my liver enzymes tripled, which alarmed me greatly.” Being a doctor herself, she knew that further chemotherapy could cause severe liver damage. Disappointed, she chose to stop treatment.
The consequences of halting treatment soon appeared: the lump under her armpit grew, her cough worsened, and signs of lung metastasis emerged. Her overall condition deteriorated. Thinking of her elder daughter, just 4 years old, and her newborn baby, she knew she had to fight—she could not give up any chance at survival. Determined, she began seeking alternative treatments abroad.
Aigerim researched medical institutions in Germany, Turkey, and China. She eventually set her sights on Fuda Cancer Hospital in Guangzhou, China, as its personalized, comprehensive treatment model impressed her. Some of its specialized techniques, she had only heard of in the U.S. and Israel. After thorough investigation, she made the bold decision to come to Fuda for treatment.

Combination Therapy Shrinks Tumors, Bringing Smiles
“I want to live.” On March 31, 2025, Aigerim was admitted to Fuda’s Medical Oncology Department IV, and these were her very first words to the medical team.
After completing necessary examinations, Associate Chief Physician Xing Yanli discovered that in addition to her left breast cancer, Aigerim also had multiple metastatic lesions in both lungs and multiple metastatic lymph nodes in the left axilla. Furthermore, small lymph nodes were found in both pulmonary hila, the right axilla, porta hepatis, retroperitoneum, and bilateral inguinal regions.
After multidisciplinary discussions and evaluations, Dr. Xing prescribed interventional arterial infusion chemotherapy combined with targeted therapy.

△ A nurse changing her dressing

“Chinese medicine, Fuda Hospital—very reliable!” During treatment, Aigerim was deeply impressed by the meticulous care, kindness, and swift responses of the Fuda medical staff.

△ Medical staff celebrating Aigerim’s birthday

After two treatment cycles, follow-up scans showed that her breast tumor had shrunk by nearly half. The axillary lymph nodes and lung metastases also reduced significantly, with some even disappearing. She then continued for three more treatment cycles, during which her tumors continued shrinking, her condition stabilized, and her weight increased by 8 kg.
When the breast tumor shrank to 3 cm, Aigerim underwent cryoablation of the left breast tumor. “The whole process was almost painless, leaving only a needle-sized wound. Afterward, I could feel the tumor softening.”
Currently, Aigerim is continuing interventional and targeted therapy. We sincerely hope she will keep recovering and getting better day by day.

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

03/09/2025

Kidney / Renal Cancer
The Function of the Kidneys and Complications Associated with Kidney Cancer
The kidneys are two bean-shaped organs located on either side of the spine, just below the rib cage. Their primary function is to filter waste products, excess water, and toxins from the blood, forming urine.

Tap: https://fudahospital.in/kidney-cancer/

.in .com

02/09/2025

[Fuda Cancer Hospital News] [Malaysia]

Founder of Malaysia’s Beacon Hospital Visits Fuda
On September 1, 2025, Ms. Mary Chen, Founder of Beacon Hospital—one of Malaysia’s renowned oncology specialty hospitals—together with Ms. Jennie Leong, CEO of ReGen Rehab Hospital, visited Fuda Cancer Hospital Guangzhou for an in-depth exchange on the hospital’s advanced minimally invasive techniques. President Niu Lizhi of Fuda Cancer Hospital, along with department heads, warmly welcomed the guests and extended their hospitality.
On-site Tour and Knowledge Sharing
Ms. Mary Chen and her delegation toured the hospital’s clinical departments and VIP wards, and engaged in conversations with Malaysian patients who were about to be discharged. They also observed interventional therapy and cryoablation procedures in action. The visitors expressed high recognition of Fuda’s patient-centered environment, superb medical expertise, and attentive healthcare services.

• Engaging in detailed discussions with Malaysian patients and their families to learn about their conditions and treatment experiences at Fuda.

• Touring the hospital facilities and gaining insights into its history and culture

• Visiting specialized departments and VIP wards
Deep Exchange for Mutual Progress
During the exchange meeting, President Niu Lizhi and Ms. Mary Chen had an in-depth discussion on minimally invasive techniques, aiming to provide higher-quality, patient-centered care for both Chinese and Malaysian patients.

President Niu noted that since its founding more than 20 years ago, Fuda Cancer Hospital has treated patients from over 110 countries and regions, with nearly 50% of its international patients coming from Southeast Asia, the Middle East, Europe, and North America—including many from Malaysia. With its minimally invasive, comprehensive, and personalized treatment approaches, the hospital has brought genuine hope to patients and effectively resolved many of the challenges faced during their treatment journeys. He expressed his hope that this visit would serve as a foundation for strengthened communication and deeper collaboration, fostering complementary advantages, mutual growth, and high-quality cooperative development that enhances patients’ sense of trust and security in seeking treatment.

The Chinese name “Bao Kang” (Beacon) conveys the meaning of “Precious Health.” Beacon Hospital is well-known in Malaysia for cancer treatment and has always adhered to a patient-centered philosophy. Its hallmark lies in offering patients the highest degree of care and warmth, breaking away from the traditional cold impression of hospitals. Ms. Mary Chen expressed her hope that through this exchange, both sides could enhance understanding of different treatment approaches and systems, promote experience sharing, technical exchanges, and practical cooperation between medical experts and institutions in both countries. Such collaboration would help elevate healthcare services in the future, providing cancer patients with more treatment options and renewed hope.
The visit concluded with an exchange of gifts and group photos to mark the occasion.

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

Address

A-302, Rustomjee Central Park (Office Spaces), Andheri-Kurla Road, Opp. Kanakia Wall-Street, Andheri (East)
Mumbai
400093

Opening Hours

Monday	10:30am - 6pm
Tuesday	10:30am - 6pm
Wednesday	10:30am - 6pm
Thursday	10:30am - 6pm
Friday	10:30am - 6pm
Saturday	10:30am - 6pm

Telephone

+918850860970

Website

http://www.fudahospital.in/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - India posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - India:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Mumbai?

Our Story

Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients.

Cancer treatment varies from patient to patient. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life.

Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family.